Alembic Pharmaceuticals rises on getting USFDA’s final approval for Deferasirox Tablets

17 Jun 2020 Evaluate
Alembic Pharmaceuticals is currently trading at Rs. 921.60, up by 14.25 points or 1.57% from its previous closing of Rs. 907.35 on the BSE.

The scrip opened at Rs. 913.90 and has touched a high and low of Rs. 932.00 and Rs. 908.00 respectively. So far 7105 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 943.00 on 16-Jun-2020 and a 52 week low of Rs. 435.10 on 21-Jun-2019.

Last one week high and low of the scrip stood at Rs. 943.00 and Rs. 815.00 respectively. The current market cap of the company is Rs. 17381.17 crore.

The promoters holding in the company stood at 72.97%, while Institutions and Non-Institutions held 15.15% and 11.88% respectively.

Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Deferasirox Tablets, 180 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Jadenu Tablets, 180 mg, of Novartis Pharmaceuticals Corporation (Novartis).

Deferasirox tablets are indicated for treatment of Chronic Iron Overload Due to Blood Transfusions (Transfusional Iron Overload) and for treatment of Chronic Iron Overload in Non-Transfusion-Dependent Thalassemia Syndromes. Alembic had previously received final approval for Deferasirox Tablets, 90 mg and 360 mg and tentative approval for Deferasirox Tablets, for 180 mg.

Deferasirox Tablets, 180 mg have an estimated market size of $53 million for twelve months ending March 2020 according to IQVIA.

Alembic now has a total of 122 ANDA approvals (109 final approvals and 13 tentative approvals) from USFDA.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of healthcare since 1907.

Alembic Pharma Share Price

991.00 -6.90 (-0.69%)
26-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.25
Dr. Reddys Lab 6263.70
Cipla 1406.25
Zydus Lifesciences 948.20
Lupin 1615.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.